Cargando…
Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
Dystrophin maintains membrane integrity as a sarcolemmal protein. Dystrophin mutations lead to Duchenne muscular dystrophy, an X-linked recessive disorder. Since dystrophin is one of the largest genes consisting of 79 exons in the human genome, delivering a full-length dystrophin using virus vectors...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020543/ https://www.ncbi.nlm.nih.gov/pubmed/36928364 http://dx.doi.org/10.1038/s41598-023-31481-3 |
_version_ | 1784908281808945152 |
---|---|
author | Hiramuki, Yosuke Abe, Satoshi Uno, Narumi Kazuki, Kanako Takata, Shuta Miyamoto, Hitomaru Takayama, Haruka Morimoto, Kayoko Takehara, Shoko Osaki, Mitsuhiko Tanihata, Jun Takeda, Shin’ichi Tomizuka, Kazuma Oshimura, Mitsuo Kazuki, Yasuhiro |
author_facet | Hiramuki, Yosuke Abe, Satoshi Uno, Narumi Kazuki, Kanako Takata, Shuta Miyamoto, Hitomaru Takayama, Haruka Morimoto, Kayoko Takehara, Shoko Osaki, Mitsuhiko Tanihata, Jun Takeda, Shin’ichi Tomizuka, Kazuma Oshimura, Mitsuo Kazuki, Yasuhiro |
author_sort | Hiramuki, Yosuke |
collection | PubMed |
description | Dystrophin maintains membrane integrity as a sarcolemmal protein. Dystrophin mutations lead to Duchenne muscular dystrophy, an X-linked recessive disorder. Since dystrophin is one of the largest genes consisting of 79 exons in the human genome, delivering a full-length dystrophin using virus vectors is challenging for gene therapy. Human artificial chromosome is a vector that can load megabase-sized genome without any interference from the host chromosome. Chimeric mice carrying a 2.4-Mb human dystrophin gene-loaded human artificial chromosome (DYS-HAC) was previously generated, and dystrophin expression from DYS-HAC was confirmed in skeletal muscles. Here we investigated whether human dystrophin expression from DYS-HAC rescues the muscle phenotypes seen in dystrophin-deficient mice. Human dystrophin was normally expressed in the sarcolemma of skeletal muscle and heart at expected molecular weights, and it ameliorated histological and functional alterations in dystrophin-deficient mice. These results indicate that the 2.4-Mb gene is enough for dystrophin to be correctly transcribed and translated, improving muscular dystrophy. Therefore, this technique using HAC gives insight into developing new treatments and novel humanized Duchenne muscular dystrophy mouse models with human dystrophin gene mutations. |
format | Online Article Text |
id | pubmed-10020543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100205432023-03-18 Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model Hiramuki, Yosuke Abe, Satoshi Uno, Narumi Kazuki, Kanako Takata, Shuta Miyamoto, Hitomaru Takayama, Haruka Morimoto, Kayoko Takehara, Shoko Osaki, Mitsuhiko Tanihata, Jun Takeda, Shin’ichi Tomizuka, Kazuma Oshimura, Mitsuo Kazuki, Yasuhiro Sci Rep Article Dystrophin maintains membrane integrity as a sarcolemmal protein. Dystrophin mutations lead to Duchenne muscular dystrophy, an X-linked recessive disorder. Since dystrophin is one of the largest genes consisting of 79 exons in the human genome, delivering a full-length dystrophin using virus vectors is challenging for gene therapy. Human artificial chromosome is a vector that can load megabase-sized genome without any interference from the host chromosome. Chimeric mice carrying a 2.4-Mb human dystrophin gene-loaded human artificial chromosome (DYS-HAC) was previously generated, and dystrophin expression from DYS-HAC was confirmed in skeletal muscles. Here we investigated whether human dystrophin expression from DYS-HAC rescues the muscle phenotypes seen in dystrophin-deficient mice. Human dystrophin was normally expressed in the sarcolemma of skeletal muscle and heart at expected molecular weights, and it ameliorated histological and functional alterations in dystrophin-deficient mice. These results indicate that the 2.4-Mb gene is enough for dystrophin to be correctly transcribed and translated, improving muscular dystrophy. Therefore, this technique using HAC gives insight into developing new treatments and novel humanized Duchenne muscular dystrophy mouse models with human dystrophin gene mutations. Nature Publishing Group UK 2023-03-16 /pmc/articles/PMC10020543/ /pubmed/36928364 http://dx.doi.org/10.1038/s41598-023-31481-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hiramuki, Yosuke Abe, Satoshi Uno, Narumi Kazuki, Kanako Takata, Shuta Miyamoto, Hitomaru Takayama, Haruka Morimoto, Kayoko Takehara, Shoko Osaki, Mitsuhiko Tanihata, Jun Takeda, Shin’ichi Tomizuka, Kazuma Oshimura, Mitsuo Kazuki, Yasuhiro Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title | Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title_full | Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title_fullStr | Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title_full_unstemmed | Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title_short | Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model |
title_sort | full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a duchenne muscular dystrophy mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020543/ https://www.ncbi.nlm.nih.gov/pubmed/36928364 http://dx.doi.org/10.1038/s41598-023-31481-3 |
work_keys_str_mv | AT hiramukiyosuke fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT abesatoshi fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT unonarumi fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT kazukikanako fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT takatashuta fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT miyamotohitomaru fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT takayamaharuka fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT morimotokayoko fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT takeharashoko fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT osakimitsuhiko fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT tanihatajun fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT takedashinichi fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT tomizukakazuma fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT oshimuramitsuo fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel AT kazukiyasuhiro fulllengthhumandystrophinonhumanartificialchromosomecompensatesformousedystrophindeficiencyinaduchennemusculardystrophymousemodel |